| ESTERASE SENSITIVE MOTIF Macrophage Pharma Limited
88158445 17 Oct 2018 | on 27 Aug 2019
| Pharmaceutical research and development services; scientific research ... Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development services; scientific research services; information, advisory, and consultancy services relating to the aforesaid | | | ESM MACROPHAGE PHARMA LIMITED
79222795 24 Jul 2017 | on 12 Jun 2018 | Chemicals for use in pharmaceuticals in the nature of chemical prepara... Class 005 Class 005 Pharmaceutical Products Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic disease Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceutical research and development services; scientific research services; information, advisory and consultancy services relating to the aforesaid | | | ESTERASE SENSITIVE MOTIF MACROPHAGE PHARMA LIMITED
79211487 09 May 2017 | on 22 May 2019 | Pharmaceutical research and development services; scientific research ... Class 005 Class 005 Pharmaceutical Products Pharmaceutical research and development services; scientific research services; information, advisory and consultancy services relating to the aforesaid Class 042 Class 042 Computer & Software Services & Scientific Services Chemicals for use in pharmaceuticals in the nature of chemical preparations for pharmaceutical purposes, namely, for use in oncology, immunotherapy, immuno-oncology and in treating metabolic disease; pharmaceutical preparations for treating cancers; pharmaceutical preparations for use in immuno-oncology; pharmaceutical preparations for use in immunotherapy; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in treating metabolic disease | | 
